Patient Case Study: Assessing Recurrence Risk in HR+/HER2- Early Breast Cancer

Patient Case Study: Assessing Recurrence Risk in HR+/HER2- Early Breast Cancer is organized by Springer Healthcare IME.

Description:
In this case study module, Sung-Bae Kim discusses key risk factors for disease recurrence in HR+/HER2- early breast cancer and outlines the prognostic tools that can be used for to help predict the risk for this, with reference to the disease course of a 34-year old HR+/HER2- early breast cancer patient.

Learning objectives
After completing this activity, you will be able to:

• Describe the prognostic variables which can influence recurrence risk in HR+HER2- early breast cancer
• Explain the methods that can help determine prognosis and treatment efficacy